MedPath

Interventional study on the reduction of thrombus using rivaroxaban for deep vein thrombosis and pulmonary thromboembolism

Not Applicable
Recruiting
Conditions
venous thromboembolism
Registration Number
JPRN-UMIN000032996
Lead Sponsor
Toho University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

under18 years old,massive or submassive PTE patients,patients with active bleeding,patients had CCr under 30ml/min

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the reduction of venous thrombus 1week,3 weeks, 3 months later after start of the treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath